Search

everythinglearnresearchcommunity

for

Search:↓

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

A new genetic change causing early stop in the androgen receptor gene was found in a patient with androgen insensitivity syndrome.

AH-001 could be a safer and more effective treatment for hair loss.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

A specific gene mutation causes vitamin D resistance, but certain vitamin D analogs might help.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Certain genetic variations in the RAB5B gene are linked to a higher risk of polycystic ovary syndrome in Chinese Han women.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Two new mutations in the AR gene linked to severe androgen insensitivity were found.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

Higher RBP4 levels are linked to severe alopecia areata, but genetic variant rs3758539 doesn't affect baricitinib response.

Genetic variations affect dutasteride treatment response for male pattern hair loss.

AHR ligands could treat inflammatory skin diseases.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Patients with the same genetic mutation for vitamin D-resistant rickets showed different symptoms but all improved with treatment except for hair loss.